Status:
COMPLETED
Lendormin D® Tablet (Drug Use Result Survey)
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Sleep Initiation and Maintenance Disorders
Eligibility:
All Genders
Brief Summary
Study to investigate the safety and the efficacy in patients with insomnia, receiving Lendormin D tablet under condition of normal clinical practice.
Eligibility Criteria
Inclusion
- Patients with insomnia
Exclusion
- none
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
485 Patients enrolled
Trial Details
Trial ID
NCT02224014
Start Date
June 1 2005
Last Update
August 22 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.